SAB Biotherapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold SABS, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
11
Funds holding
$5795305
Total value held
Buying
11 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackstone Inc. | $3294451 | 860170 | +860170 | NEW BUY |
| 2 | Blackrock, Inc. | $1154079 | 301326 | +284087 | +1647.93% |
| 3 | Goldman Sachs Group Inc | $436390 | 113940 | +62592 | +121.90% |
| 4 | State Street Corp | $284305 | 74231 | +61109 | +465.70% |
| 5 | Northern Trust Corp | $219942 | 57426 | +41014 | +249.90% |
| 6 | Bank Of America Corp /De/ | $213320 | 55697 | +45084 | +424.80% |
| 7 | Citigroup Inc | $112103 | 29974 | +29142 | +3502.64% |
| 8 | Morgan Stanley | $49324 | 158350 | +7649 | +5.08% |
| 9 | Pnc Financial Services Group, Inc. | $29491 | 7700 | +7700 | NEW BUY |
| 10 | Barclays Plc | $1900 | 496 | +496 | NEW BUY |
| 11 | Royal Bank Of Canada | $0 | 1 | +1 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.